What is Aardvark Therapeutics, Inc. Common Stock?
, a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. was incorporated in 2017 and is headquartered in San Diego, California. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 20.20M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.